The TRANSMET study, initially presented at ASCO, provided new data on liver...
Professor Wakelee from Stanford, United States, presented the final DFS...
The final analysis of the DESTINY-Lung02 trial, a dose-blinded phase 2...
Dr Iris Dirven, a medical oncologist in training at the University Hospital of...
Prof Emmanuel Seront, a medical oncologist at Clinique Universitaires Saint-Luc...
A presentation at ASCO focused on the quality of life of patients undergoing...
At the ASCO Congress, the results of a study on a non-invasive tool to assess...
The AEGEAN and Checkmate 77T trials investigated perioperative chemotherapy...
The ADAURA trial, which investigated adjuvant osimertinib for patients with...
Dr Willem Lybaert, a medical oncologist affiliated with VITAZ Sint-Niklaas and...